Germline predispositions in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)

DDX41 and its Unique Contribution to Myeloid Leukemogenesis | OncotargetПодробнее

MDS 2023: PS 5 - Predisposition to MDSПодробнее

Discovery of a new predisposition gene, ERG, for bone marrow failure and hematological malignancyПодробнее

Insights into the biology of pediatric MDSПодробнее

The importance of studying the genetic landscape of myeloid malignanciesПодробнее

Germline Pre-disposition to Myeloid MalignanciesПодробнее

SESSION I BIOLOGY OF MDS (English) - Latin-American GLAM and MDSF Symposium 2021Подробнее

SESSION I BIOLOGY OF MDS (Spanish) -Latin-American GLAM and MDSF Symposium 2021Подробнее

From MDS to AML: Understanding the Pathology, Diagnostics, and Genetic Relationship 10/10/17Подробнее

How close are we to implementing germline precision medicine in acute myeloid leukemia?Подробнее

Do genetic tests on suspected MDS cases identify familial mutations that can cause these diseases?Подробнее

Developing an understanding of disease progression in MDS and AMLПодробнее

How can the study of familial leukemias help us to understand sporadic leukemias?Подробнее